Dow Jones received a payment from EQS/DGAP to publish this press release.
Eli Lilly and Company
Eli Lilly and Company: ELI LILLY AND COMPANY FILES FORM 3, FORM 4, and FORM
5
02-Apr-2019 / 16:51 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
ELI LILLY AND COMPANY FILES FORM 3, FORM 4, and FORM 5
INDIANAPOLIS, April 2, 2019 - Eli Lilly and Company (NYSE / Euronext Paris /
SIX: LLY) today informs its shareholders that one or more initial statements
of beneficial ownership on Form 3 and statements of changes in beneficial
ownership of its officers and directors on Form 4, and annual statement of
changes in beneficial ownership on Form 5, as required by Section 16(a) of
the U.S. Securities Exchange Act of 1934, as amended, have been filed or
will be filed shortly with the U.S. Securities and Exchange Commission
("SEC").
Lilly makes available free of charge on its website, its Annual Report on
Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K,
reports filed pursuant to Section 16 of the U.S. Securities Exchange Act of
1934 and amendments to those reports filed with or furnished to the SEC as
soon as reasonably practicable after Lilly electronically files these
documents with, or furnishes them to, the SEC. These documents are posted on
Lilly's website at www.lilly.com - under "Investors."
The SEC maintains a website that contains reports, proxy statements and
other information regarding issuers that file electronically with the SEC.
These materials may be obtained electronically by accessing the SEC's home
page at www.sec.gov.
Copies of the above referenced information will also be made available, free
of charge, upon written request to the Company's secretary at Lilly
Corporate Center, Indianapolis, Indiana 46285, U.S.A.
Regulatory filing PDF file
Document title: ELI LILLY AND COMPANY FILES FORM 3, FORM 4, and FORM 5
Document: http://n.eqs.com/c/fncls.ssp?u=CQRWNTXQXY [1]
Language: English
Company: Eli Lilly and Company
Lilly Corporate Center
46285 Indianapolis
United States
Phone: +1-317-276-2000
E-mail: hern_kevin_r@lilly.com
Internet: https://www.lilly.com/
ISIN: US5324571083
Euronext Ticker: LLY
AMF Category: Other news releases
EQS News ID: 794981
End of Announcement EQS News Service
794981 02-Apr-2019 CET/CEST
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=7657444af9520866ed9f32fe6c61440d&application_id=794981&site_id=vwd&application_name=news
(END) Dow Jones Newswires
April 02, 2019 10:51 ET (14:51 GMT)
© 2019 Dow Jones News
